AI-Powered smartwatches could cut hospital readmissions after heart attacks

NCT ID NCT07288229

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a smartwatch combined with artificial intelligence can improve recovery for people who have had a heart attack. 200 adults aged 18-75 who recently had a heart attack and a stent placed will wear a smartwatch that tracks health data. The AI analyzes this data and gives personalized advice on medications, diet, and activity. The goal is to see if this approach reduces unplanned hospital readmissions and improves heart function over three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

wearable device with AI-guided data analysis

What this could lead to

If successful, this could provide a personalized, AI-driven approach to monitor and manage heart attack recovery at home, potentially reducing the need for hospital readmission.

What could go wrong

This is a small, early-stage study (200 participants) with no control group, so results may not apply broadly. The technology depends on patients consistently wearing the device and following recommendations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••